Standout Papers
Immediate Impact
9 from Science/Nature 27 standout
Citing Papers
Mapping the effectiveness and risks of GLP-1 receptor agonists
2025 Standout
Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
2024 StandoutScience
Works of Yuko Tsuge being referenced
Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study
2022
A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a Part
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yuko Tsuge | 192 | 53 | 35 | 49 | 11 | 242 | |
| Genki Ichihashi | 189 | 53 | 35 | 48 | 7 | 238 | |
| Kawthar Mohamed | 160 | 47 | 61 | 57 | 12 | 263 | |
| Qin Mao | 203 | 64 | 47 | 34 | 5 | 284 | |
| Pauline Brun | 189 | 48 | 39 | 26 | 8 | 269 | |
| Victoria Dulière | 204 | 50 | 39 | 26 | 8 | 284 | |
| Paola Magro | 164 | 27 | 33 | 22 | 13 | 265 | |
| Zheng Yao Low | 152 | 20 | 73 | 53 | 12 | 269 | |
| Jarosław Przybyciński | 128 | 38 | 63 | 23 | 11 | 274 | |
| Collin S Hill | 168 | 26 | 46 | 18 | 9 | 211 | |
| Minoosh Shabani | 149 | 53 | 29 | 30 | 15 | 250 |
All Works
Loading papers...